Bortezomib

Bortezomib is used in the treatment of multiple myeloma and mantle-cell lymphoma.

Bortezomib is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in a number of proteins in the cancer cells leading to their death.

Low blood platelets, Anemia (low number of red blood cells), Decreased white blood cell count (neutrophils), Fungal infection, Breathlessness, Dehydration, Itching, Dry skin, High blood pressure, Erythema (skin redness), Gastrointestinal bleeding, Decreased white blood cell count (lymphocytes), Herpes zoster, Pneumonia, Lymphopenia, Decreased potassium level in blood, Decreased sodium level in blood, Decreased calcium level in blood, Motor neuropathy, Orthostatic hypotension (sudden lowering of blood pressure on standing), Edema (swelling)